IQGEN Holdings LLC has struck two more deals from its maiden health-tech fund, Vantage, and has ramped up its team to boost its activity in Asia, the healthcare investment and advisory firm's founder told VCCircle. Aman Iqbal, who is also managing partner at IQGEN, said Vantage has invested in Stelvio Therapeutics, ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
